Skip to main content

Sifalimumab

Multi tool use
Multi tool use







Sifalimumab


From Wikipedia, the free encyclopedia

Jump to navigation
Jump to search























Sifalimumab

Sifalimumab 4YPG.png

Fab fragment of sifalimumab bound to IFN-α2A. From PDB: 4ypg​.

Monoclonal antibody
Type
Whole antibody
Source
Human
Target
Interferon α
Clinical data
ATC code
  • none

Identifiers
CAS Number

  • 1143503-67-6 ☒N

ChemSpider
  • none

UNII
  • XOY1YA7RMC

KEGG
  • D09668

Chemical and physical data
Formula
C6518H10008N1724O2032S38
Molar mass
146.25 kg/mol

 ☒N☑Y (what is this?)  (verify)

Sifalimumab is a human monoclonal antibody designed for the treatment of SLE, dermatomyositis, and polymyositis. It targets interferon a.[1]


Sifalimumab was developed by MedImmune; as of 2017 development had been terminated in favor of moving a competing internal product, anifrolumab, into Phase III trials.[2][3][4]



References[edit]



  1. ^ "Statement On A Nonproprietary Name Adopted By The USAN Council: Sifalimumab" (PDF). American Medical Association..mw-parser-output cite.citationfont-style:inherit.mw-parser-output qquotes:"""""""'""'".mw-parser-output code.cs1-codecolor:inherit;background:inherit;border:inherit;padding:inherit.mw-parser-output .cs1-lock-free abackground:url("//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png")no-repeat;background-position:right .1em center.mw-parser-output .cs1-lock-limited a,.mw-parser-output .cs1-lock-registration abackground:url("//upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png")no-repeat;background-position:right .1em center.mw-parser-output .cs1-lock-subscription abackground:url("//upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png")no-repeat;background-position:right .1em center.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registrationcolor:#555.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration spanborder-bottom:1px dotted;cursor:help.mw-parser-output .cs1-hidden-errordisplay:none;font-size:100%.mw-parser-output .cs1-visible-errorfont-size:100%.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-formatfont-size:95%.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-leftpadding-left:0.2em.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-rightpadding-right:0.2em


  2. ^ "Press release: New Hope for Lupus Patients". MedImmune. 11 August 2015. Archived from the original on 31 July 2017.


  3. ^ "Sifalimumab". AdisInsight. Retrieved 31 July 2017.


  4. ^ "Sifalimumab". NHS Specialist Pharmacy Service. Retrieved 31 July 2017.














Retrieved from "https://en.wikipedia.org/w/index.php?title=Sifalimumab&oldid=793186070"





Navigation menu

























(window.RLQ=window.RLQ||).push(function()mw.config.set("wgPageParseReport":"limitreport":"cputime":"0.492","walltime":"0.773","ppvisitednodes":"value":4227,"limit":1000000,"ppgeneratednodes":"value":0,"limit":1500000,"postexpandincludesize":"value":129859,"limit":2097152,"templateargumentsize":"value":2633,"limit":2097152,"expansiondepth":"value":16,"limit":40,"expensivefunctioncount":"value":1,"limit":500,"unstrip-depth":"value":1,"limit":20,"unstrip-size":"value":10026,"limit":5000000,"entityaccesscount":"value":1,"limit":400,"timingprofile":["100.00% 651.923 1 -total"," 80.17% 522.632 1 Template:Drugbox"," 60.38% 393.630 1 Template:Infobox"," 11.18% 72.865 4 Template:Cite_web"," 9.36% 60.998 16 Template:Unbulleted_list"," 6.79% 44.264 1 Template:Infobox_drug/chemical_formula"," 6.46% 42.126 9 Template:Navbox"," 2.89% 18.810 1 Template:Monoclonals_for_immune_system"," 2.33% 15.210 1 Template:Cytokine_receptor_modulators"," 2.30% 14.966 1 Template:Chem_molar_mass"],"scribunto":"limitreport-timeusage":"value":"0.171","limit":"10.000","limitreport-memusage":"value":4227874,"limit":52428800,"cachereport":"origin":"mw1273","timestamp":"20181011011350","ttl":1900800,"transientcontent":false);mw.config.set("wgBackendResponseTime":80,"wgHostname":"mw1326"););19MKO X4D4
8J1,bXNSYqgjdNc,75L,vXQ9p2sasUNoq5LyhsLVH7RJOySsdh1,aJKL STbX1yyswHE1iIX6aFksH,53e,B

Popular posts from this blog

The Dalles, Oregon

영화 미래의 미라이 다시보기 (2018) 다운로드 링크 무료보기

Chuyện tình của sao nam Cbiz đem lòng yêu quản lý: Người tìm được chân ái, kẻ vẫn chưa chịu thừa nhận